Search Results 91-100 of 824 for ���������������������������������������������:PC90���

1. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

2. A Study of Single Patient Investigational Drug CPI-613 for Use in Treatment-Refractory, Metastatic Prostate Cancer - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) - Mayo Clinic

   This study will evaluate the efficacy of ranolazine as compared with placebo when used as part of standard medical therapy in chronic angina subjects with ...

5. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

6. Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer - Mayo Clinic

   The purpose of this study is to determine whether DCVAC/PCa added onto Standard of Care Chemotherapy can improve survival times for patients with Metastatic ...

7. https://www.mayoclinic.org/spanish_organization_concepts.xml

8. https://www.mayoclinic.org/chinese_patient_consumer_web.xml

9. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) - Mayo Clinic

   About this study. The purpose of this study is to demonstrate the superiority of MD1003 (300 mg/day) over placebo to clinically improve patients with ...

10. Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors - Mayo Clinic

    Mayo Clinic and our partners use technologies such as cookies to collect information from your browser to deliver relevant advertising on our site, in emails ...